Financial Ratios

BIOGEN PHARMACHEM INDUSTRIES LTD.

NSE : NABSE : 531752ISIN CODE : INE703D01023Industry : TradingHouse : Om Prakash Jindal
BSE1.14-0.02 (-1.72 %)
PREV CLOSE ( ) 1.16
OPEN PRICE ( ) 1.10
BID PRICE (QTY) 1.13 (38649)
OFFER PRICE (QTY) 1.14 (36325)
VOLUME 420470
TODAY'S LOW / HIGH ( )1.10 1.16
52 WK LOW / HIGH ( ) 0.621.85
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.010.00-0.020.00
   CEPS(Rs)0.010.00-0.020.00
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.840.830.830.850.83
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-0.61-98.80-0.37
   EBIT Margin(%)-0.34-98.80-0.37
   Pre Tax Margin(%)-0.35-98.81-0.37
   PAT Margin (%)-0.35-98.81-0.37
   Cash Profit Margin (%)-0.35-98.81-0.37
Performance Ratios
   ROA(%)0.83-0.02-2.91-0.21-0.01
   ROE(%)0.84-0.02-2.92-0.21-0.01
   ROCE(%)0.84-0.02-2.91-0.21-0.01
   Asset Turnover(x)0.000.050.030.000.02
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.002.210.660.000.14
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.00
   Receivable days0.001188.422893.16
   Inventory Days0.000.000.00
   Payable days15.00218.81
Valuation Parameters
   PER(x)84.290.000.000.000.00
   PCE(x)84.530.00-8.55-106.25-4230.75
   Price/Book(x)0.711.690.250.220.28
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)36.898.4416.46
   EV/Core EBITDA(x)84.230.00-8.54-108.85-4467.70
   EV/EBIT(x)84.230.00-8.54-108.85-4467.70
   EV/CE(x)0.701.660.250.230.27
   M Cap / Sales36.938.4515.80
Growth Ratio
   Net Sales Growth(%)-100.0052.48-100.00
   Core EBITDA Growth(%)5523.8199.48-1273.79-3234.1999.95
   EBIT Growth(%)5523.8199.48-1273.79-3234.1999.95
   PAT Growth(%)5396.5199.46-1273.83-3189.2799.95
   EPS Growth(%)7100.0099.59-1275.70-3189.2799.95
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.010.01
   Current Ratio(x)0.652.3723.64198.397.06
   Quick Ratio(x)0.652.3723.64198.397.06
   Interest Cover(x)4556.00-42.000.00-73.22
   Total Debt/Mcap(x)0.000.000.000.020.04

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.